Dager S R, Saal A K, Comess K A, Dunner D L
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Hosp Community Psychiatry. 1988 May;39(5):517-27. doi: 10.1176/ps.39.5.517.
Confusing and contradictory results have emerged from studies of the relationship between anxiety disorders and mitral valve prolapse (MVP), a commonly occurring heart defect that has been associated with chest pain, palpitations, tachycardia, and arrhythmias. Patients with anxiety disorders, particularly panic attacks, appear to have an increased prevalence of MVP compared with control groups or the general population, although most individuals with MVP are asymptomatic. MVP does not appear to distinguish a subgroup of patients with panic disorder on the basis of vulnerability to panic attacks, symptom presentation, biological abnormalities, or treatment response. The authors review some current hypotheses about causal relationships between anxiety disorders and MVP, describe methods of diagnosing MVP and their shortcomings, and identify possible medical complications of MVP and ways to treat or prevent them.
关于焦虑症与二尖瓣脱垂(MVP)之间关系的研究结果令人困惑且相互矛盾。二尖瓣脱垂是一种常见的心脏缺陷,与胸痛、心悸、心动过速及心律失常有关。与对照组或普通人群相比,焦虑症患者,尤其是惊恐发作患者,似乎MVP的患病率更高,尽管大多数MVP患者并无症状。MVP似乎无法根据对惊恐发作的易感性、症状表现、生物学异常或治疗反应来区分惊恐障碍患者亚组。作者回顾了当前一些关于焦虑症与MVP因果关系的假说,描述了MVP的诊断方法及其不足之处,并确定了MVP可能的医学并发症以及治疗或预防这些并发症的方法。